Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dutasteride Dose-Ranging Study in Androgenetic Alopecia
NCT01231607Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2010
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of dutasteride in androgenetic alopecia (AGA), sponsored by GSK. Started Oct 2010; status: completed.
02
Drugs
dutasteride
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT01231607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01231607.